Total Funding
57
60
Total FundingVenture - Series Unknown raised
Growth Score
2 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
21115
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
Acquired by 
Linden Capital Partners
- Daniel Orlando: CEO
- Shaheda Ahmed: Senior Scientific Officer
About the Company
Alcresta is developing and commercializing innovative, point-of-care, enzyme-based nutritional products that support improved nutrition and manage disease for infants, aging adults and people battling acute conditions or chronic diseases. Alcresta’s research-based approach is innovative, proprietary and driven by the unmet nutritional needs of
those people with compromised health. Alcresta’s core capabilities include expertise in adult and pediatric nutrition, as well as protein manufacturing expertise and regulatory experience that support the development and commercialization of its programs. The company’s platform is supported by the Alcresta team’s proven success in developing protein therapeutics.
Women Founded
